{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:55:30Z","timestamp":1792454130081,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI104681"],"award-info":[{"award-number":["UM1AI104681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI114508"],"award-info":[{"award-number":["R21AI114508"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,6]]},"DOI":"10.1093\/cid\/cix783","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T15:10:37Z","timestamp":1503933037000},"page":"163-171","source":"Crossref","is-referenced-by-count":613,"title":["Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae"],"prefix":"10.1093","volume":"66","author":[{"given":"David","family":"van Duin","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith J","family":"Lok","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and the Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Earley","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and the Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Cober","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra S","family":"Richter","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Perez","sequence":"additional","affiliation":[{"name":"Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio"},{"name":"Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Salata","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C","family":"Kalayjian","sequence":"additional","affiliation":[{"name":"Department of Medicine, MetroHealth Medical Center, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R","family":"Watkins","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, Ohio"},{"name":"Division of Infectious Diseases, Cleveland Clinic Akron General, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Doi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith S","family":"Kaye","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Vance G","family":"Fowler","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"},{"name":"Division of Infectious Diseases, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Paterson","sequence":"additional","affiliation":[{"name":"University of Queensland Centre for Clinical Research, Royal Brisbane and Women\u2019s Hospital Campus, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Bonomo","sequence":"additional","affiliation":[{"name":"Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio"},{"name":"Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio"},{"name":"Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio"},{"name":"Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and the Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Antibacterial Resistance Leadership Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"key\n\t\t\t\t20180328155234_CIT0001","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0002","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv086","article-title":"Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study","volume":"70","author":"Tumbarello","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328155234_CIT0003","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1128\/AAC.03007-15","article-title":"Combination regimens for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections","volume":"60","author":"Gomez-Simmonds","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328155234_CIT0004","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cmi.2016.01.016","article-title":"Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"22","author":"Falcone","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180328155234_CIT0005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmi.2016.01.023","article-title":"Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections","volume":"22","author":"Hauck","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180328155234_CIT0006","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2012.11.009","article-title":"Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes","volume":"75","author":"van Duin","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0007","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1473-3099(16)00057-8","article-title":"Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1","volume":"16","author":"Yao","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0008","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0009","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/ciw805","article-title":"Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality","volume":"64","author":"Rojas","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0011","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/cid\/ciw491","article-title":"Ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae bacteremia","volume":"63","author":"Wu","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0012","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/ciw636","article-title":"Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections","volume":"63","author":"Shields","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0013","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamainternmed.2016.4362","article-title":"States worse than death among hospitalized patients with serious illnesses","volume":"176","author":"Rubin","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20180328155234_CIT0014","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.02636-14","article-title":"Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network","volume":"58","author":"van Duin","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328155234_CIT0015","doi-asserted-by":"crossref","DOI":"10.1017\/ice.2015.298","article-title":"Hospital readmissions in patients with carbapenem-resistant Klebsiella pneumoniae","author":"Messina","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20180328155234_CIT0016","doi-asserted-by":"crossref","first-page":"O1117","DOI":"10.1111\/1469-0691.12714","article-title":"Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance","volume":"20","author":"van Duin","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180328155234_CIT0017","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180328155234_CIT0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0019","article-title":"Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2014","journal-title":"CLSI"},{"key":"key\n\t\t\t\t20180328155234_CIT0020","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/jac\/dkr240","article-title":"Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009)","volume":"66","author":"Lascols","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328155234_CIT0021","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/cid\/cis036","article-title":"\u201cSilent\u201d dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio","volume":"54","author":"Viau","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0022","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/civ495","article-title":"Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR)","volume":"61","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0023","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"key\n\t\t\t\t20180328155234_CIT0024","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"Hern\u00e1n","year":"2000","journal-title":"Epidemiology"},{"key":"key\n\t\t\t\t20180328155234_CIT0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/19466315.2015.1094406","article-title":"Comment: fundamentals and innovation in antibiotic trials","volume":"7","author":"Evans","year":"2015","journal-title":"Stat Biopharm Res"},{"key":"key\n\t\t\t\t20180328155234_CIT0026","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/19466315.2016.1207561","article-title":"Using outcomes to analyze patients rather than patients to analyze outcomes: a step toward pragmatism in benefit:risk evaluation","volume":"8","author":"Evans","year":"2016","journal-title":"Stat Biopharm Res"},{"key":"key\n\t\t\t\t20180328155234_CIT0027","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0028","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1473-3099(16)30004-4","article-title":"Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study","volume":"16","author":"Carmeli","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328155234_CIT0029","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/21505594.2016.1213473","article-title":"Methods and issues in studies of CRE","volume":"8","author":"Evans","year":"2017","journal-title":"Virulence"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/66\/2\/163\/24468519\/cix783.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:03:29Z","timestamp":1750809809000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/66\/2\/163\/4103289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,9,4]]},"published-print":{"date-parts":[[2018,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix783","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1,15]]},"published":{"date-parts":[[2017,9,4]]}}}